An open-labeled trial of adjunctive donepezil for cognitive impairments in patients with schizophrenia
- 28 December 2001
- journal article
- clinical trial
- Published by Elsevier in Schizophrenia Research
- Vol. 59 (1) , 29-33
- https://doi.org/10.1016/s0920-9964(01)00387-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Cholinergic Enhancement and Increased Selectivity of Perceptual Processing During Working MemoryScience, 2000
- Cholinesterase Inhibitors: A New Class of Psychotropic CompoundsAmerican Journal of Psychiatry, 2000
- The Effects of Atypical Antipsychotic Drugs on Neurocognitive Impairment in Schizophrenia: A Review and Meta-analysisSchizophrenia Bulletin, 1999
- The Influence of Ondansetron and m-Chlorophenylpiperazine on Scopolamine-Induced Cognitive, Behavioral, and Physiological Responses in Young Healthy ControlsBiological Psychiatry, 1998
- Presynaptic Nicotinic Receptors Facilitate Monoaminergic TransmissionJournal of Neuroscience, 1998
- Schizophrenia, Sensory Gating, and Nicotinic ReceptorsSchizophrenia Bulletin, 1998
- Inhibitory Gating of an Evoked Response to Repeated Auditory Stimuli in Schizophrenic and Normal SubjectsArchives of General Psychiatry, 1996
- The Effects of Clozapine on Symptom Reduction, Neurocognitive Function, and Clinical Management in Treatment-Refractory State Hospital Schizophrenic InpatientsNeuropsychopharmacology, 1996
- What are the functional consequences of neurocognitive deficits in schizophrenia?American Journal of Psychiatry, 1996
- Studies of Motor Function in Schizophrenia: II. Reaction TimeThe Journal of General Psychology, 1937